CytoDyn Inc CYDY

Healthcare Biotechnology

CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells. It has studied leronlimab in multiple therapeutic areas, including infectious disease, oncology, and autoimmune conditions. The Company has conducted clinical trials of leronlimab as a viral entry inhibitor for human immunodeficiency virus (HIV), believed to competitively bind to the N-terminus and second extracellular loop of the CCR5 receptor. For immunology, the CCR5 receptor is believed to be implicated in immune-mediated illnesses such as Metabolic dysfunction-associated steatohepatitis. It has a joint development agreement with a third-party generative artificial intelligence (AI) drug discovery and development company to develop one or more longer-acting molecules.

OTCQB:CYDY - Post by User

CytoDyn Inc > Thank you Shorts

<< Previous

Bullboard Posts

Next >>

Post by theNormon Mar 10, 2021 4:48pm

222 Views

Post# 32765561

Thank you Shorts

I don't know why CYDY hasn't gotten off the otcbb's. Too busy building a company and arranging multiple trials I guess is the only excuse.
I embrace everything so thank you shorts for making this a buying opportunity again. GOTCHA, SUCKERS LOL

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario